Henry Hoppe
Corporate Officer/Principal at Xenetic Biosciences (UK) Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard J. Cohen | M | 73 |
Massachusetts Institute of Technology
| 45 years |
| James Parslow | M | 59 |
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | - |
| Phillip Sharp | M | 79 |
Massachusetts Institute of Technology
| 50 years |
| Dimitri Antoniadis | M | 77 |
Massachusetts Institute of Technology
| 46 years |
| Alexander M. Klibanov | M | 74 |
Massachusetts Institute of Technology
| 45 years |
| Colin William Hill | M | 79 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 17 years |
| Michael Scott Maguire | M | 61 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 20 years |
| John D. Joannopoulos | M | - |
Massachusetts Institute of Technology
| 46 years |
| Thomas L. Neff | M | - |
Massachusetts Institute of Technology
| 49 years |
| Sanjay Jain | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 23 years |
| Brad Marcus | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 17 years |
| Donald R. Sadoway | M | - |
Massachusetts Institute of Technology
| 46 years |
| Marc Kastner | M | 78 |
Massachusetts Institute of Technology
| 51 years |
| Fiorella Kostoris | F | 79 |
Massachusetts Institute of Technology
| 44 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gregory Gregoriadis | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 17 years |
| Peter Zieve | M | 70 |
Massachusetts Institute of Technology
| 8 years |
| Emanuel M. Sachs | M | - |
Massachusetts Institute of Technology
| 9 years |
| Mark A. Clements | M | - |
Massachusetts Institute of Technology
| 3 years |
| Roger McCarthy | M | 75 |
Massachusetts Institute of Technology
| 5 years |
| On-kwok Li | M | 69 |
Massachusetts Institute of Technology
| 8 years |
| Greg L. Zacharias | M | - |
Massachusetts Institute of Technology
| 3 years |
| Harry Atwater | M | - |
Massachusetts Institute of Technology
| 10 years |
| Louis S. Metzger | M | - |
Massachusetts Institute of Technology
| 10 years |
| Poh Kam Wong | M | 72 |
Massachusetts Institute of Technology
| 9 years |
| Adnan Akant | M | - |
Massachusetts Institute of Technology
| 5 years |
| Montgomery Alger | M | 67 |
Massachusetts Institute of Technology
| 5 years |
| Edward E. David | M | 99 |
Massachusetts Institute of Technology
| 43 years |
| Gregg Burgess | M | - |
Massachusetts Institute of Technology
| 5 years |
| Michael Perlmutter | M | 73 |
Massachusetts Institute of Technology
| 6 years |
| Bob Frankston | M | - |
Massachusetts Institute of Technology
| 5 years |
| Curtis Lockshin | M | 64 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 3 years |
| Beth A. Marcus | M | - |
Massachusetts Institute of Technology
| 5 years |
| Jon Hirschtick | M | - |
Massachusetts Institute of Technology
| 5 years |
| Brian Daniels | M | 65 |
Massachusetts Institute of Technology
| 4 years |
| Gabriel Richard Bitran | M | - |
Massachusetts Institute of Technology
| 5 years |
| Jocelyn E. Scott | F | - |
Massachusetts Institute of Technology
| 4 years |
| Barbara Poggiali | M | 61 |
Massachusetts Institute of Technology
| 5 years |
| Steven C. Webster | M | 67 |
Massachusetts Institute of Technology
| 5 years |
| Sylvester James Gates | M | 73 |
Massachusetts Institute of Technology
| 8 years |
| Steve Brown | M | - |
Massachusetts Institute of Technology
| 5 years |
| Michael Paluszek | M | - |
Massachusetts Institute of Technology
| 6 years |
| Mark Gus Alexandridis | M | 66 |
Massachusetts Institute of Technology
| 6 years |
| Tom A. Stefanick | M | - |
Massachusetts Institute of Technology
| 5 years |
| Joseph de Angelo | M | - |
Massachusetts Institute of Technology
| 6 years |
| Mark Jennings | M | 63 |
Massachusetts Institute of Technology
| 5 years |
| Ruben Ojeda | M | - |
Massachusetts Institute of Technology
| 6 years |
| Kyu-Ha Cung | M | 72 |
Massachusetts Institute of Technology
| 7 years |
| Gregory D. Hawkins | M | - |
Massachusetts Institute of Technology
| 8 years |
| Zaurie Zimmerman | F | - |
Massachusetts Institute of Technology
| 6 years |
| Brian Jacobs | M | 63 |
Massachusetts Institute of Technology
| 5 years |
| Grant Norman Smith | M | 72 |
Massachusetts Institute of Technology
| 5 years |
| John Robert Chisholm | M | - |
Massachusetts Institute of Technology
| 7 years |
| Elizabeth Marie Robinson | M | - |
Massachusetts Institute of Technology
| 4 years |
| Bob Goodof | M | - |
Massachusetts Institute of Technology
| 5 years |
| Bill S. Elkus | M | - |
Massachusetts Institute of Technology
| 3 years |
| Ethan E. Jacks | M | 70 |
Massachusetts Institute of Technology
| 5 years |
| John A. DeTore | M | - |
Massachusetts Institute of Technology
| 7 years |
| George Economou | M | 71 |
Massachusetts Institute of Technology
| 5 years |
| J. Wargo | M | 69 |
Massachusetts Institute of Technology
| 6 years |
| Brian E. Foody | M | - |
Massachusetts Institute of Technology
| 5 years |
| Rebecca M. Henderson | M | 63 |
Massachusetts Institute of Technology
| 4 years |
| Gary Pace | M | 76 |
Massachusetts Institute of Technology
| 3 years |
| Alex Makowski | M | - |
Massachusetts Institute of Technology
| 4 years |
| David S. Keselica | M | - |
Massachusetts Institute of Technology
| 4 years |
| Harry Ruda | M | 65 |
Massachusetts Institute of Technology
| 3 years |
| Anil Bhaskar Chaudhary | M | - |
Massachusetts Institute of Technology
| 1 years |
| Shirley Jackson | M | 77 |
Massachusetts Institute of Technology
| 3 years |
| Tom Reed | M | - |
Massachusetts Institute of Technology
| 4 years |
| Brian NeSmith | M | 62 |
Massachusetts Institute of Technology
| 4 years |
| David Chang | M | 64 |
Massachusetts Institute of Technology
| 4 years |
| Daryl J. Carter | M | 69 |
Massachusetts Institute of Technology
| 1 years |
| Robert Mehrabian | M | 82 |
Massachusetts Institute of Technology
| 7 years |
| Elaine Kant | M | - |
Massachusetts Institute of Technology
| 4 years |
| Gregory B. Olson | M | - |
Massachusetts Institute of Technology
| 3 years |
| Thomas Sciascia | M | 70 |
Massachusetts Institute of Technology
| 4 years |
| Michael Whitehead | M | - |
Massachusetts Institute of Technology
| 4 years |
| Aziz Asphahani | M | - |
Massachusetts Institute of Technology
| 3 years |
| Kevin Mayer | M | 62 |
Massachusetts Institute of Technology
| 4 years |
| Jae-Hak Kim | M | 75 |
Massachusetts Institute of Technology
| 1 years |
| Sidney M. Hecht | M | 80 |
Massachusetts Institute of Technology
| 8 years |
| Myron Samuel Scholes | M | 82 |
Massachusetts Institute of Technology
| 4 years |
| Steve Hall | M | 69 |
Massachusetts Institute of Technology
| 3 years |
| Alex Lightman | M | 63 |
Massachusetts Institute of Technology
| 4 years |
| Steve E. Math | M | - |
Massachusetts Institute of Technology
| 4 years |
| Stephen Cucchiaro | M | - |
Massachusetts Institute of Technology
| 4 years |
| Thomas H. Lee | M | 64 |
Massachusetts Institute of Technology
| 4 years |
| Jeffrey G. MacIntosh | M | - |
Massachusetts Institute of Technology
| 4 years |
| Nick Nocerino | M | - |
Massachusetts Institute of Technology
| 6 years |
| Roger King | M | - |
Massachusetts Institute of Technology
| 4 years |
| Samer Khanachet | M | 73 |
Massachusetts Institute of Technology
| 4 years |
| Andrew Meade | M | - |
Massachusetts Institute of Technology
| 4 years |
| Julian Adams | M | 69 |
Massachusetts Institute of Technology
| 3 years |
| Ron Kallus | M | 74 |
Massachusetts Institute of Technology
| 4 years |
| Scott Howard Shlecter | M | - |
Massachusetts Institute of Technology
| 4 years |
| Chi-Won Yoon | M | 65 |
Massachusetts Institute of Technology
| 4 years |
| Morris Kesler | M | - |
Massachusetts Institute of Technology
| 4 years |
| Michael Jeffrey Abrams | M | 68 |
Massachusetts Institute of Technology
| 3 years |
| Rudi Lamprecht | M | 75 |
Massachusetts Institute of Technology
| 4 years |
| Monroe W. Robertson | M | 74 |
Massachusetts Institute of Technology
| 1 years |
| Alan Spoon | M | 72 |
Massachusetts Institute of Technology
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 93 | 93.00% |
| United Kingdom | 7 | 7.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Henry Hoppe
- Personal Network
